<DOC>
	<DOCNO>NCT02572713</DOCNO>
	<brief_summary>The purpose study measure alpha-synuclein peripheral body tissue fluids Parkinson 's disease ( PD ) . This may help develop good treatment PD patient future .</brief_summary>
	<brief_title>Systemic Synuclein Sampling Study ( S4 )</brief_title>
	<detailed_description>This multi-center , cross-sectional , observational study evaluate α-syn pathology multiple tissue biofluids individual subject PD HC single time point .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Inclusion Criteria ( PD subject ) : Male female age 40 old time PD diagnosis . Clinical diagnosis PD base bradykinesia plus one following : rest tremor rigidity . DAT deficit screen base visual interpretation DaTSCAN™ imaging . PD subject need fall one follow stage : Early untreated PD require dopamine replacement medication ( anticholinergic , MAOB inhibitor amantadine permit ) , Hoehn Yahr 12 , &lt; 2 year diagnosis . Moderate PD responsive currently treat dopamine replacement therapy without evidence motor fluctuation dyskinesias . Advanced PD motor fluctuation dyskinesias , &gt; 5 year diagnosis . Ability provide write informed consent accordance Good Clinical Practice ( GCP ) , International Conference Harmonization ( ICH ) , local regulation . Willing able comply schedule visit , require study procedure laboratory test . Inclusion Criteria ( HC subject ) : Male female age 50 old time screen visit Ability provide write informed consent accordance Good Clinical Practice ( GCP ) , International Conference Harmonization ( ICH ) , local regulation . Willing able comply schedule visit , require study procedure laboratory test . Exclusion Criteria ( subject ) : Has history cancer ( basal squamous cell skin cancer ) , autoimmune disorder , liver disease , hematological disorder within past 5 year . Current treatment anticoagulant ( e.g. , Coumadin , heparin ) would preclude safe completion lumbar puncture ( LP ) tissue biopsy procedure . Current treatment antiplatelet agent ( Plavix aspirin &gt; 325 mg/day ) . Has diagnosis diabetes mellitus require either oral agent insulin therapy . A bleeding diathesis , clinically significant coagulopathy thrombocytopenia . Has receive botulinum toxin injection submandibular gland within past year . Has condition precludes safe performance routine LP , prohibitive lumbar spinal disease . Has condition precludes safe performance flexible sigmoidoscopy procedure may interfere obtain evaluable colonic tissue biopsy , include prior colonoscopy significant finding ( e.g . polyp positive finding , ulcerative colitis , Crohn 's disease , inflammatory disease ) . Has condition precludes safe performance submandibular gland procedure may interfere obtain evaluable submandibular tissue biopsy , include previous active significant disease affect submandibular gland ( e.g . inflammatory disease , infection , tumor ) . Has condition precludes safe performance skin punch biopsy procedure may interfere obtain evaluable skin tissue biopsy , include previous active significant dermatological disease ( e.g . previous biopsy follow finding : inflammatory disease , scar tissue , psoriasis , keloid formation , skin cancer ) . Any medical psychiatric condition laboratory abnormality , opinion Site Investigator would preclude participation . Use investigational drug device within 30 day prior screen visit . Exclusion criterion ( PD subject ) : Has significant neurological disorder ( clinically significant stroke , brain tumor , hydrocephalus , epilepsy , neurodegenerative disorder , encephalitis , repeat head trauma , polyneuropathy ) . Has significant autonomic dysfunction ( symptomatic orthostasis , hypotension urinary incontinence ) suggestive atypical parkinsonism . Has atypical feature parkinsonism include limited supranuclear gaze palsy , early recurrent fall , corticospinal track abnormality , cerebellar abnormality , significant cognitive dysfunction . Exclusion criterion ( HC subject ) : Has family history PD firstdegree relative . Has significant neurological disorder ( neurodegenerative condition , clinically significant stroke , brain tumor , hydrocephalus , epilepsy , neurodegenerative disorder , encephalitis , repeat head trauma , polyneuropathy ) . Has Montreal Cognitive Assessment ( MoCA ) score less 26 . Has diagnosis REM sleep behavior disorder . Has primary dystonia , restless legs syndrome , essential tremor , movement disorder .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Parkinson 's Disease</keyword>
	<keyword>alpha-synuclein</keyword>
	<keyword>biomarker</keyword>
</DOC>